This week, one NL Central team has acquired the best defender at a key infield position. He’ll be playing the 2021 season at age-30, and he was below average offensively in 2020, so it’s not as though there aren’t red flags, but great defense doesn’t grow on trees. That’s right: the Brewers signed Kolten Wong to a two-year, $18 million contract, as Jon Morosi first reported.

While Nolan Arenado might have fallen behind Matt Chapman in the third base defense hierarchy, Wong reigns supreme at second. For three straight years, he’s won the Fielding Bible award at second base. Every advanced defensive metric sees him as the best fielder in the game over the past three years. Bigger fan of the eye test? He can do this:

Okay, fine, single defensive highlights are a bad reflection of talent. But he can do this, too:

I could go on all day if there weren’t an article to write. Wong is one of my very favorite players to watch. This is a transaction analysis, though, so I’ll restrain myself, and merely say that our very good defensive projections for Wong might still be conservative. Read the rest of this entry »

Ben Lindbergh and Meg Rowley recap the Rockies’ press conference about the Nolan Arenado trade and GM Jeff Bridich claiming the belt as the game’s most-maligned GM, then discuss Angels pitching coach Mickey Callaway’s suspension and Andrelton Simmons’ comments about his mental state in 2020, analyze the Twins re-signing Nelson Cruz and signing Alex Colomé, the Rays reuniting with Chris Archer, the Reds adding Sean Doolittle, and the Brewers landing Kolten Wong, touch on A.J. Preller’s promotion and extension and examine the potential conflict between Theo Epstein’s MLB consultancy and his new private-equity job, and conclude with a Stat Blast about the incredible consistency of Leroy Stanton.

Audio intro: Earth Girls, "Only Human"
Audio outro: Matthew Sweet, "Split Personality"

Link to Emma Baccellieri on the Rockies
Link to Marc Carig on the Rockies
Link to Nick Groke on the Arenado trade
Link to story about Monfort’s 94-win prediction
Link to Ben Clemens on Arenado’s new deal
Link to The Athletic report about Callaway
Link to Ginny Searle on Callaway
Link to Jeff Passan on Drew Robinson
Link to Jeff Fletcher on Simmons
Link to Kevin Goldstein on the Cruz signing
Link to Clemens on Cruz last September
Link to EW episode about Cruz
Link to Tony Wolfe on the Archer signing
Link to Ben on the Archer trade
Link to story about Archer’s sinker usage
Link to report about Epstein’s new gig
Link to Dan Fox on platoon splits
Link to Stanton’s career splits page

 iTunes Feed (Please rate and review us!)
 Sponsor Us on Patreon
 Facebook Group
 Effectively Wild Wiki
 Twitter Account
 Get Our Merch!
 Email Us: podcast@fangraphs.com

Podcast (effectively-wild): Play in new window | Download

Subscribe: RSS

Read the rest of this entry »

Maybe the Rays are getting nervous. Two and half months ago, they watched Charlie Morton sign with Atlanta as a free agent. About a month later, they traded staff ace Blake Snell to San Diego. Those were the two best starters on a team that leaned heavily on its rotation, but Tampa’s only addition so far this winter has been embattled right-hander Michael Wacha at a mere $3 million. Meanwhile, the Blue Jays have landed one major free agent after another, and the Yankees still look very much like a juggernaut. As of Tuesday morning, Tampa Bay ranked 10th in the American League in our Depth Charts projected WAR standings — fourth in the AL East — just a few months after winning the pennant.

But with spring training (theoretically) fast approaching, the Rays finally signed another starting pitcher on Tuesday, adding a familiar face to the rotation.

Right-hander Chris Archer and the Tampa Bay Rays are in agreement on a one-year, $6.5 million deal, pending physical, sources tell ESPN.

Archer, 32, returns to the organization where he debuted and found his greatest success.

— Jeff Passan (@JeffPassan) February 2, 2021

To be clear, Chris Archer is no replacement for the starters Tampa Bay lost this winter. He’s posted an ERA over 4.00 in each of his last four seasons and missed all of 2020 after undergoing surgery to treat neurogenic thoracic outlet syndrome. Effectiveness in the first season back from that injury — one of the most serious a pitcher can experience — is far from guaranteed. Tampa’s familiarity with Archer, however, made the team willing to bet on the 32-year-old right-hander anyway.

Read the rest of this entry »

From the moment the offseason officially started five days after the end of the World Series, the most predictable headline of the winter was “Nelson Cruz Signs One-Year Deal With the Twins.” It took three months, but last night it finally happened, with ESPN’s Jeff Passan reporting the signing and MLB.com’s Mark Feinsand adding that the deal will net Cruz $13 million.

Cruz, who turns 41 in July, is an ageless wonder, even though that number gives teams looking at eight-figure investments significant pause. Two years ago, he was a free agent after an exceptional run with the Mariners during which he put up a 147 wRC+ and averaged 41 home runs a season. He lobbied hard for a two-year deal, but most teams countered with one-year offers. It was understandable: Cruz has been defying the aging curve for years and has no value beyond the bat, so if Father Time suddenly catches up to him, he becomes a candidate for a quick release. Back in 2019, he was pushing 39 and coming off a declining season in terms of your standard triple-slash line, but the underlying metrics looked good, as his strikeout rate was actually declining, and his exit velocities were in line. Still, most models would not be especially kind to Cruz or any player entering his age-39 season. These are not the years when players start to slip a little; they’re the ones when players fall off the cliff.

Here at FanGraphs, Cruz ranked as one of the top 20 free agents on the market that winter, and I was shocked, surprised and frankly quite impressed to see that ZiPS still saw the good in the player, projecting a minor bounce-back 2019 campaign at .266/.348/.500. The Twins took the plunge by meeting Cruz halfway on his multi-year demand, paying him $14 million for the 2019 campaign with a $12 million option for the following year.

They were rewarded amply. Instead of falling of the cliff, Cruz instead rocketed higher, putting up a career-high OPS of 1.031 and making his 2020 option a no-brainer. The cliff avoided him again that season, and the production was similar.

Read the rest of this entry »

After breaking apart their bullpen in an effort to cut costs, the Reds took a step towards rebuilding it on Tuesday, agreeing to terms with 34-year-old lefty Sean Doolittle on a one-year deal with a base salary of $1.5 million plus as-yet-unspecified incentives. For as modest an expenditure as it is, Doolittle is just the second major league free agent the Reds have signed this winter from outside the organization (Kyle Farmer was signed to a new major league deal after previously being non-tendered). The two-time All-Star has ample experience closing, something in short supply on the Reds’ current roster, but in order to return to any kind of high-leverage duty, he’ll need to rebound from what was largely a lost season.

Doolittle, who spent his past 3 1/2 seasons with the Nationals, made just 11 appearances totaling 7.2 innings in 2020. He landed on the Injured List twice, first missing nearly three weeks in August due to inflammation in his right knee, and then being shelved for the remainder of the season after straining an oblique muscle in mid-appearance on September 10. For what it’s worth — perhaps not much given the sample sizes, though it merits a look to compare to his track record — his average fastball velocity and performance had been trending upwards after the first IL stint, as you can see here:

Doolittle didn’t allow a run over his final six appearances, after being scored upon in four out of five previously, so there’s that, a point to which we’ll return. Read the rest of this entry »

I obviously don’t have access to MLB Trade Rumors’ site traffic data, so it’s an educated guess that “[Team] Signs [Player] To a Minor League Contract” pieces are among their least trafficked pages. I get it. Big trades and big free agent acquisitions are exciting. Some vet trying to hang on and being given another chance? Not so much. That said, the world of minor league contracts for veterans is one that I was very close to during my time in baseball. The first time I was given the assignment of negotiating these deals, I thought they would be simple. I quickly learned they were anything but. Unless something dramatic and unexpected happens in terms of the labor negotiations between the league and the players, spring training is close. With an unprecedented number of free agents still out there, plenty of these types of deals are being negotiated as we speak, so it’s a good time to get into what it takes to get a deal over the line.

Opportunity

The crux of any minor league contract negotiation is opportunity. Players don’t want to be in the minor leagues. The focus is on playing in the majors, and which potential employer gives them the best chance to spend significant time in the big leagues. The reasons are obvious. They get paid like big leaguers, they accrue service time, and the perks (better per diems, charter flights, opulent hotels, palatial clubhouses) are phenomenal.

Agents don’t talk about money or contract clauses first, they talk about the possibility of their player being with the big league club. I would imagine that every Quad-A shortstop right now has his agent in touch with the Reds, while avoiding clubs like the Mets, Padres and others where the position is filled by a star-level talent who tends to stay on the field. Agents for these players become depth chart aficionados, studying every team’s situation across various position families to see where their player might slide in.

Personally, I always tried to be honest with agents and players with regards to said opportunity. Sometimes a team is offering the player a real chance to break camp with the big club; sometimes they are clearly a depth piece meant to bide their time at Triple-A until someone gets hurt or drastically underperforms. And yes, sometimes you do find yourself in direct contact with players. I always appreciated the conversations, and thought it spoke well of the player on a makeup level, as the individual was personally invested in the process.

Beyond the chances to play in the big leagues, clubs need to sell potential roster pieces on the additional benefits of joining the team. For the Astros, the player development system and the club’s ability to communicate data-based improvements was a big part of the pitch. Often players wanted to speak to someone more important than the negotiator, like the GM or field manager, just to hear assurances from the source themselves. Read the rest of this entry »

Hey everyone, and welcome to the convergence of two recurring segments. It’s the highly awaited crossover between “Can You Believe the Cardinals Got Nolan Arenado for That?” and “Let’s Value Gimmicky Contracts,” two columns I almost assuredly enjoy writing more than you enjoy reading.

Let’s get the deferred money part out of the way first, because while it’s obviously very important to the Rockies and Cardinals, it has nothing to do with Arenado’s decision-making. He’s getting his cash, and whether the check says Monfort or DeWitt, the cash still spends the same. It won’t affect his decision on whether to rip the whole contract up.

As Jeff Jones reported, Arenado agreed to modify his contract as part of the trade. In 2021, he was due $35 million. Now, he’ll receive $15 million this year, paid directly by the Rockies. He’ll also receive $20 million in deferred compensation, regardless of whether or not he opts out. If he’s still under this contract, that money will be sent to the Cardinals, who will then pay it to Arenado. If he opts out, the Rockies will pay him the $20 million directly.

Finally, if Arenado doesn’t opt out, the Rockies will be on the hook for the $16 million he’s due in 2027. That’s the new year that the Cardinals agreed to as part of the trade, and while it’s unclear exactly why the Rockies chose to pay that part rather than some pro-rated portion of earlier salaries, here we are.

For the Cardinals, this is a great fit. They’d been acting as though cash was a key constraint this year, and getting a year of Arenado at no cost (literally, no monetary cost!) does a good job of making the short-term books work. In the long run, they’re paying him nothing for one year (if he opts out after 2021), $35 million over two years (if he opts out after 2022), or $164 million over seven years.

With that covered, let’s talk about Arenado’s options. The structure is as straightforward as it gets for these kinds of things. After 2021, Arenado will have the option to walk away from the entire deal and become a free agent. If he opts to remain in St. Louis, he’ll get another chance to wash his hands of the deal after 2022. If he still wants to stay, then he’ll be under contract until after the 2027 season.

When Arenado signed his extension two years ago, I covered a probabilistic way of thinking about the value. In the interim, a few things have happened. First, Arenado had a down 2020. Second, Dan “Dr. ZiPS” Szymborski gave me a long-term forecast for Arenado that beats my generic aging expectations. Finally, I’ve added a few bells and whistles to the option model in the interim. For the most part, though, we’re just running it back.

To calculate the value of an opt out, we need a few things. First, a central projection for how good a player will be in the future. ZiPS is all over that. Here’s the next five years of Arenado’s projections:

I’ll assume a standard aging curve after that, which gets us a central tendency for how his career will go.

Next, we need to apply variance. I’ve found in previous studies that projections for players who fit Arenado’s mold — mid-career and projections above 2 WAR — vary with a standard deviation of roughly 1.4 WAR from year to year. We’ll start with projections as a baseline, but to figure out the value of an option — the right but not obligation to do something — we’ll have to simulate 10 million or so different futures, then work out what happens on average.

Finally, we need to figure out how to translate Arenado’s projections into a potential new contract. Converting WAR to dollars misses some team-building effects, and as Craig Edwards showed last year, it’s not as simple as applying a linear conversion. Still, it’s my model, and it’s just for Arenado, not for the dang league as a whole. Let’s start with $8 million per win.

While we’re varying projections, we also need to vary the cost of a win. I assumed that the cost of 1 WAR will increase by an average of $250,000 per year, but with a standard deviation of $800,000. In plenty of years, the cost of a win will go down, even if the overall cost increases over time. There might be, say, a global pandemic, or a shortened season with no fans… wild nonsense like that.

Finally, we get down to brass tacks. When the player reaches his opt out, there’s a simple calculation. Take his new median projection, age it down as appropriate, and come up with a WAR projection for the remaining years of the contract. Multiply that number by the cost per win that we simultaneously calculated, and you have the contract that Arenado would sign, in a perfectly efficient market, if he opted out. I added one quick sanity check: if it’s within $10 million dollars of breaking even, Arenado won’t leave. That represents the uncertainty of finding a new contract, as well as the benefits of familiarity.

If there were only one opt out, our calculation would be simple. After one year, we simply apply an aging penalty and a random change in projection. Then, we use that to price out a new contract. With only one year before an opt out, things are simple like that.

In Arenado’s case, the odds are stacked in favor of him declining the opt out. The average situation (no change in projection) sees him with a $101.5 million contract after this year. He’d need to raise his 2022 projection by roughly 1.5 WAR to merit a contract that would be worth opting out for. How often does that happen? Roughly 14% of the time.

Let’s look at it more thoroughly. Here’s how much he projects to make in each scenario, including the $35 million he’s making in 2021 regardless:

In that sense, the opt out already in Arenado’s contract is “worth” $6 million. It could be worth more, though. Replace our forecasts with the ZiPS forecasts that ignore 2020 (they used 2019’s rate stats again), and instead things get a little spicy:

Hey, look! If Arenado were projected to be a bit better — and again, injury has at least something to do with why he’s not — then his option would be worth more. Neat stuff!

That’s not why you’re here, though. Or, maybe it is, but that’s not what Arenado’s contract looks like anymore. In agreeing to head to St. Louis, Arenado gained an extra opt out after the 2022 season.

It’s slightly tricky to model nested opt outs like this, where the second one can only be exercised if the first isn’t. In practice, the decision won’t be overly complex. After 2021, Arenado and his agents will model something that looks a lot like the calculations I did above, valuing his existing contract based on his current projections and including a 2022 opt out. That number will come out to something higher than $180 million, because some amount of the time, he’ll opt out after 2022 and get a raise.

With that number in hand, they’ll approximate what he could get on the open market and compare the two. If he thinks he can get more now, on the open market, than the value of his existing contract inclusive of the opt out, he should leave. Otherwise, he should stay and wait the extra year to see what happens.

Unfortunately, that doesn’t work well in my framework. In each of my 10 million simulations, computer Arenado would need to run 10 million simulations to work out the value of his option using this Monte Carlo method. That comes out to one hundred trillion simulations, and it doesn’t even add much precision for our trouble. Instead, I’m just setting the cutoff higher; Arenado will need $15 million in prospective gains to pull the trigger on opting out after year one.

How does this change things? Less than you’d think. I previously calculated that Arenado would opt out 14% of the time; he now opts out 12.4% of the time in year one. With more time to vary, and thus a higher percent chance of improving enough to opt out, he also has an 8.2% chance of opting out after 2022. All together, that looks like this:

In the scenarios where Arenado opts out after 2022, he is, on average, quite good. This makes sense, because he’s only opting out in the best 8% of scenarios. If he muddles along, he’s staying. If he has a late-career renaissance, it only stands to reason that he’ll be more valuable. All told, the two opt outs add a projected $13 million to the value of the deal — not bad!

Once more, let’s plug in a more optimistic view of Arenado and see what shakes out. This is Dan’s pre-2020 version, where he’s projected for 5 WAR in 2021:

Again, the better Arenado is now, the higher the chance he opts out, and the more the second opt out is worth to him. In the base case ZiPS projections, a second opt out added roughly $6 million to Arenado’s expected earnings. In this pre-injury case, a second opt out would add more than $17 million.

That’s the gory math of the way this complex contract works. In practice, however, Arenado seems likely to take the Clayton Kershaw route. Kershaw, too, had the choice of opting out of his contract early and becoming a free agent. He used that leverage to get the Dodgers to offer him a new contract, avoiding free agency but monetizing his ability to leave. Even if Arenado improves this year and next, that seems like the most likely eventuality.

What’s an opt out worth? In Arenado’s case, it’s real money in expectation. Add that to the extra contract year that he snagged as part of the deal, and it’s easy to see why the player’s union was okay with him taking deferrals in 2021. Remember, though: even in the scenario where he’s at his best, he still leaves less than half the time. It’s valuable despite being unlikely, and that’s the magic of options.

For years, there’s been one refrain in Anaheim: get Mike Trout some pitching help. The last time an Angels pitcher accrued 4 or more WAR was Garrett Richards in 2014, and there’s been a carousel of arms in the half-decade since. Yesterday, the Angels wholly misunderstood that refrain, sending Jahmai Jones to Baltimore in exchange for professionally cromulent starter Alex Cobb.

Cobb, who is in the last year of a four-year, $57 million contract, reached free agency after years of quiet competence. In the three intervening years, he’s alternated between being competent or hurt. He gets to it in a strange way — few strikeouts, fewer walks, and enough grounders to blot out the sun — but it adds up to something a little worse than average but significantly better than replacement level.

For the Angels, that may or may not be a meaningful upgrade to start the season. Shohei Ohtani will return in 2021, but certainly not for the whole season. When he does, he’ll likely be part of a six-man rotation. The top three starters will be Andrew Heaney, Dylan Bundy, and new acquisition José Quintana. That leaves two spots for other pitchers. Before the acquisition of Cobb, that meant Griffin Canning and Patrick Sandoval. Both are interesting, albeit unproven, options. Read the rest of this entry »